A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data

This 2-year trial evaluated the efficacy and tolerability of a monthly oral regimen of risedronate. Postmenopausal women with osteoporosis were randomly assigned to double-blind treatment with risedronate 75 mg on 2 consecutive days each month (2CDM) or 5 mg daily. The primary end point was the perc...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	McClung, Michael R., Benhamou, Claude-Laurent, Man, Zulema, Tlustochowicz, Witold, Zanchetta, Jose R., Eusebio, Rachelle, Balske, Ana M., Matzkin, Ellen, Olszynski, Wojciech P., Recker, Robert, Delmas, Pierre D.
Format:	Artigo
Sprog:	Inglês
Udgivet:	Springer-Verlag 2012
Fag:	Original Research
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3528955/ https://ncbi.nlm.nih.gov/pubmed/23150144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-012-9668-4
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data

Lignende værker